Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Obesity is being missed at alarming rates — especially in Japan. A large study of over 6.7 million adults found that nearly 30% of eligible U.S. adults and a staggering 97.7% of Japanese adults with elevated BMI never received an obesity diagnosis. Those who were diagnosed carried a significantly heavier burden of related conditions like diabetes, heart failure, and sleep apnea.
A large observational study published in Obesity analyzed data from more than 6.7 million adults with elevated BMI in the U.S. and Japan between 2016 and 2024. The findings are striking: while 70.1% of qualifying U.S. adults received an obesity diagnosis, only 2.3% of Japanese adults did — meaning the vast majority are going undiagnosed despite meeting clinical criteria. Researchers point to stigma, lack of disease recognition, and inadequate healthcare infrastructure as key drivers.
The gap in diagnosis isn't just a paperwork problem — it has real health consequences. Adults with an obesity diagnosis consistently showed higher rates of comorbidities like hypertension, type 2 diabetes, and heart failure compared to undiagnosed peers, suggesting that undiagnosed individuals may be missing out on coordinated, comprehensive care.
By the Numbers:
Why it matters: With powerful new obesity treatments like GLP-1 agonists now available, closing the diagnosis gap is more urgent than ever. Researchers suggest tools like automated EMR alerts when a BMI threshold is recorded could help primary care providers catch and treat obesity before complications compound.
